Grant: Engage Grants Program
University of Manitoba
$24,992.00
Development of Flow Chemistry Techniques: Resolution of Problematic Industrial Process Chemistry Reactions
EF 2017-18
Résumé
Analogues of natural products are known to be an abundant reservoir for medicinally relevant compounds, withmany such molecules being commercialized into therapeutically useful drugs, such as cancer therapies.Historically, considerable effort in the field of organic chemistry has been applied to the development of newsynthetic methods for the construction of these natural products and their respective therapeutically usefulderivatives. Although many synthetic transformations have been developed, new synthetic methods areurgently required to make syntheses shorter, safer, greener and more atom economical. It is the goal of thisresearch project to resolve problematic process chemistry reactions that have been identified by Dalton PharmaServices by creating new flow chemistry-based methods that will be used in the synthesis of activepharmaceutical ingredients (API), which are commonly derivatives of natural products. Specifically, we willdevelop new flow-based synthesis protocols for i) reductions using lithium aluminum hydride (LiAlH4) and ii)reduction of alkynes to alkenes that are suitable for process scale applications. Currently, these types ofreactions are particularly problematic to perform on large scale due to safety and reactivity problems that areinherent to batch chemistry reactions. To solve these issues, we will develop flow chemistry synthetic protocolsthat will replace these current process scale batch methods (vide infra). The field of flow chemistry is poised tohave a transformative effect on the discipline of organic synthesis by avoiding the costly, inefficient methods ofbatch, and replacing them with superior methods that allow for safer, greener and more proficient chemicaltransformations. In its simplest form, flow chemistry replaces conventional fixed-volume batch reaction flaskswith flow microreactors, hence the term ""flow"" chemistry. This research project plans to utilize the benefits offlow chemistry and develop continuous flow processes that will solve the problems that are inherent whenscaling-up these batch reactions. Overall, resolving the problematic batch reactions that have been identified byDalton Pharma Services, and yield much more cost-effective and safer chemical processes.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
514829-2017
Name nom
Tranmer, Geoffrey
Department département
Pharmacy, Faculty of
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
24992
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Development of Flow Chemistry Techniques: Resolution of Problematic Industrial Process Chemistry Reactions
Keyword
NSERC
Application summary
Analogues of natural products are known to be an abundant reservoir for medicinally relevant compounds, withmany such molecules being commercialized into therapeutically useful drugs, such as cancer therapies.Historically, considerable effort in the field of organic chemistry has been applied to the development of newsynthetic methods for the construction of these natural products and their respective therapeutically usefulderivatives. Although many synthetic transformations have been developed, new synthetic methods areurgently required to make syntheses shorter, safer, greener and more atom economical. It is the goal of thisresearch project to resolve problematic process chemistry reactions that have been identified by Dalton PharmaServices by creating new flow chemistry-based methods that will be used in the synthesis of activepharmaceutical ingredients (API), which are commonly derivatives of natural products. Specifically, we willdevelop new flow-based synthesis protocols for i) reductions using lithium aluminum hydride (LiAlH4) and ii)reduction of alkynes to alkenes that are suitable for process scale applications. Currently, these types ofreactions are particularly problematic to perform on large scale due to safety and reactivity problems that areinherent to batch chemistry reactions. To solve these issues, we will develop flow chemistry synthetic protocolsthat will replace these current process scale batch methods (vide infra). The field of flow chemistry is poised tohave a transformative effect on the discipline of organic synthesis by avoiding the costly, inefficient methods ofbatch, and replacing them with superior methods that allow for safer, greener and more proficient chemicaltransformations. In its simplest form, flow chemistry replaces conventional fixed-volume batch reaction flaskswith flow microreactors, hence the term ""flow"" chemistry. This research project plans to utilize the benefits offlow chemistry and develop continuous flow processes that will solve the problems that are inherent whenscaling-up these batch reactions. Overall, resolving the problematic batch reactions that have been identified byDalton Pharma Services, and yield much more cost-effective and safer chemical processes.